Definitive Contract HR001119C0060

The Department of Defense's Defense Advanced Research Projects Agency (DARPA) awarded a $8,761,470.00 firm fixed-price contract to Dnarx LLC, a small disadvantaged business, for the Preemptive Expression of Protective Alleles and Response Elements (PREPARE) program. The PREPARE program aims to develop programmable gene modulators for humans that can provide specific, effective, safe, and transient medical countermeasures and prophylaxes to combat chemical, biological, radiological, and/or nuclear (CBRN) threats. This contract does not have a set-aside designation and the period of performance is scheduled to conclude on July 31, 2021. The contract was awarded on April 1, 2019 based on a pre-solicitation posted on June 6, 2018.